Journal of Immunotherapy

Aims & Scope

Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy.

Laboratory and preclinical studies, as well as investigative clinical reports, are presented.

The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic.

JIT contains full-length articles, review articles, and short communications.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.9
2024	3.20

Journal Rank

Year	Value
2024	3530

Journal Citation Indicator

Year	Value
2024	426

SJR (SCImago Journal Rank)

Year	Value
2024	1.203

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	108

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

  Citation: 989

  Authors: Richard E., Catherine, Keli, Aarti, Marybeth, Udai S., Richard M., Suzanne L., James C., Israel, Steven A.

• Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

  Citation: 947

  Authors: Richard A., Nachimuthu, Daniel, Alena, Paul F., Zhili, Mark E., Steven A., James C., Richard M., Giao Q., Marybeth S., Udai S., Akemi D., Crystal J., Ashley A., Nicholas P., Martha M., Meghna, Avi Z., Avindra, Tongguang, Bibiana, Simone C., Nirmala, Francis J., Susanne, Barbara, Dolores J., Carolyn M., Steven A.

• Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients

  Citation: 592

  Authors: Mark E., John R., Thomas E., Jos, Steven A.

• Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

  Citation: 564

  Authors: James C., Marybeth, Udai, Richard, Richard M., Suzanne L., Kimberly B., Catherine, Tamika, Sharon, Israel, Donald E., Steven A.

• Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer

  Citation: 444

  Authors: Dung T., Eric, Jennifer N., Elizabeth A., Beth, Sara, Lei, Luis A., Ross C., Elizabeth M., Daniel A.

• Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b

  Citation: 428

  Authors: John A., An, Adham, Martin, Malcolm K., Cliona M., Aaron E.

• IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells

  Citation: 358

  Authors: Steven A., Claude, Mojgan, Terry J., Lien T., Susan L., Maryalice, Kathleen E., Sharon A., Michel, Renaud, Crystal L., Ronald E.

• Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor

  Citation: 345

  Authors: James N., Steven A., Yangbing, Hui, Mary A., Richard A., Wyndham H., Steven A.

• Induction of Cytokine Production from Human Monocytes Stimulated with Alginate

  Citation: 333

  Authors: Marit, Kjetill, Gudmund, Olav, Patrick, Terje

• PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors

  Citation: 324

  Authors: Kevin C., Agnieszka A., Annie A., Kelly, Qian, Yi, Anthony, Elaine, Eric, Linda, Sheng, Robert A., Daniel, Christopher L., Barish H., Richard D., Elizabeth M., Lei

---